Soleno Therapeutics (SLNO) Other Working Capital Changes (2016 - 2019)
Historic Other Working Capital Changes for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to -$42000.0.
- Soleno Therapeutics' Other Working Capital Changes fell 12079.21% to -$42000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was -$360000.0, marking a year-over-year decrease of 70000.0%. This contributed to the annual value of $750000.0 for FY2024, which is 1039.43% down from last year.
- Per Soleno Therapeutics' latest filing, its Other Working Capital Changes stood at -$42000.0 for Q4 2019, which was down 12079.21% from -$79000.0 recorded in Q3 2019.
- Soleno Therapeutics' Other Working Capital Changes' 5-year high stood at $202000.0 during Q4 2018, with a 5-year trough of -$175000.0 in Q2 2018.
- Its 5-year average for Other Working Capital Changes is -$18759.1, with a median of -$29000.0 in 2017.
- In the last 5 years, Soleno Therapeutics' Other Working Capital Changes crashed by 870000.0% in 2015 and then surged by 92857.14% in 2016.
- Quarter analysis of 5 years shows Soleno Therapeutics' Other Working Capital Changes stood at -$57630.0 in 2015, then tumbled by 142.15% to -$139552.0 in 2016, then surged by 241.88% to $198000.0 in 2017, then grew by 2.02% to $202000.0 in 2018, then plummeted by 120.79% to -$42000.0 in 2019.
- Its last three reported values are -$42000.0 in Q4 2019, -$79000.0 for Q3 2019, and -$122000.0 during Q2 2019.